The UBC Therapeutics Initiative (TI) has released a new, patient-friendly handout that explains why oral (PO) antibiotics are often preferred over intravenous (IV) options. Developed with input from patient partners, the 1-page resource uses plain language and visual design to support shared decision-making and reduce unnecessary IV antibiotic use. 

Click here for the 1-page patient resource: 

Why oral instead of IV antibiotics? 

And here for adapted version for  ED waiting room TV: 

Oral vs IV antibiotic Slide 

Additional information and resources:

• Therapeutics Letter #155 outlining evidence behind PO over IV antibiotics 

• A webinar with Dr. Davie Wong addressing common myths and sharing clinical case examples